We expect to derive the majority of our revenue from license fees and royalties associated with these patents,” VirnetX plainly states on its Web site.
It hasn’t done badly. On Monday, the company announced second-quarter revenues of $200 million, up nearly 28,000-fold from the $7,200 it earned in the same quarter in 2009.
graph. ground. anyway. now!
A blogpost by the company’s Malware Protection Centre (MMPC) said one particular “family” of malware, dubbed “Sality”, had increased its attacks over the past week. “Sality is a highly virulent strain,” warns Holly Stewart of MMPC. “It is known to infect other files (making full removal after infection challenging), copy itself to removable media, disable security, and then download other malware. It is also a very large family – one of the most prevalent families this year.”